Understanding low COVID-19 booster uptake among US adults-Reference-Cited by-同舟云学术

Understanding low COVID-19 booster uptake among US adults

Published:2023-10 Issue:42 Volume:41 Page:6221-6226
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Jacobs Elizabeth T.^ORCID,Cordova-Marks Felina M.,Farland Leslie V.,Ernst Kacey C.,Andrews Jennifer G.^ORCID,Vu Sage,Heslin Kelly M.^ORCID,Catalfamo Collin^ORCID,Chen Zhao,Pogreba-Brown Kristen

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference22 articles.

1. Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022;Wu;Lancet Respir Med,2023

2. Estimated effectiveness of COVID-19 vaccines against omicron or delta symptomatic infection and severe outcomes;Buchan;JAMA Netw Open,2022

3. Effectiveness of bivalent boosters against severe omicron infection;Lin;N Engl J Med,2023

4. Efficacy and safety of COVID-19 vaccines;Graña;Cochrane Database Syst Rev,2022

5. Estimation of vaccine effectiveness of CoronaVac and BNT162b2 against severe outcomes over time among patients with SARS-CoV-2 omicron;Wei;JAMA Netw Open,2023

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal annual COVID-19 vaccine boosting dates following previous booster vaccination or breakthrough infection;2024-07-26

2. COVID-19 Vaccine Side Effects and Long-Term Neutralizing Antibody Response;Annals of Internal Medicine;2024-07

3. COVID-19 Booster Vaccination Status and Long COVID in the United States: A Nationally Representative Cross-Sectional Study;Vaccines;2024-06-20

4. COVID-19 point-of-care tests can identify low-antibody individuals: In-depth immunoanalysis of boosting benefits in a healthy cohort;Science Advances;2024-06-14

5. Diabetes and COVID-19 Outcomes: An Analysis of Freeman Health System Patients;Cureus;2024-02-15